China Nuokang Bio-Pharmaceutical: China Watch
By Brittany Umar | By David Peltier
NEW YORK--David Peltier, Stocks Under $10 Portfolio Manager, details this week's IPO of China Nuokang Bio-Pharmaceutical and highlights interesting changes happening within the China IPO space.
04:00AM 12/11/09
Movers Roundup: MCG Capital, Thomas & Betts
Movers roundup: MCG Capital shares surge to annual high, Thomas & Betts stock jumps on upgrade
05:46PM 09/29/09
RegeneRx Jumps On Positive Preclinical Study Data
RegeneRx soars on positive data from preclinical study of multiple sclerosis drug candidate
02:29PM 09/29/09
Here's a look back at the hits, misses and notable moments from 2008.
12:20PM 12/29/08
Biotech Mailbag: Bad CEOs Offer Lessons
Senior Columnist Adam Feuerstein's selection of Kelly Martin as the worst biotech CEO for 2008 highlights the need for investors to scrutinize management teams before plunging into an investment.
11:08AM 12/19/08
Biotech Mailbag: Bad CEOs Offer Lessons (RealMoney.com $)
Senior Columnist Adam Feuerstein's selection of Kelly Martin as the worst biotech CEO for 2008 highlights the need for investors to scrutinize management teams before plunging into an investment.
07:01AM 12/19/08
It May Be Time to Renovate Your Home
Amid the housing downturn, improvements could still add value to your abode.
01:38PM 03/05/08
Wednesday's Health Winners & Losers
Kosan rises on news of a partnership with Pfizer.
11:30AM 12/20/06
How to Make the Right Sector Calls (RealMoney.com $)
Take a walk through the numbers that can point the way to the coming year's strongest sectors.
12:41PM 09/12/06



Connect with TheStreet